Wastewater treatment: processes, management strategies and environmental/health impacts
Gespeichert in:
Weitere Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Hauppauge, New York
Nova Science Publishers, Inc.
[2014]
|
Schriftenreihe: | Environmental science, engineering and technology series
|
Schlagworte: | |
Online-Zugang: | FAW01 FAW02 |
Beschreibung: | Print version record |
Beschreibung: | 1 online resource |
ISBN: | 9781634824910 1634824911 9781634824675 1634824679 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV043784722 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 160920s2014 |||| o||u| ||||||eng d | ||
020 | |a 9781634824910 |9 978-1-63482-491-0 | ||
020 | |a 1634824911 |9 1-63482-491-1 | ||
020 | |a 9781634824675 |9 978-1-63482-467-5 | ||
020 | |a 1634824679 |9 1-63482-467-9 | ||
035 | |a (ZDB-4-EBA)ocn912876812 | ||
035 | |a (OCoLC)912876812 | ||
035 | |a (DE-599)BVBBV043784722 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-1046 |a DE-1047 | ||
082 | 0 | |a 628.3 |2 23 | |
130 | 0 | |a Wastewater treatment (Hauppauge, N.Y.) | |
245 | 1 | 0 | |a Wastewater treatment |b processes, management strategies and environmental/health impacts |c editors, Lydia M. Barrett |
264 | 1 | |a Hauppauge, New York |b Nova Science Publishers, Inc. |c [2014] | |
300 | |a 1 online resource | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Environmental science, engineering and technology series | |
500 | |a Print version record | ||
505 | 8 | |a WASTEWATER TREATMENT: PROCESSES, MANAGEMENT STRATEGIES AND ENVIRONMENTAL/HEALTH IMPACTS; WASTEWATER TREATMENT: PROCESSES, MANAGEMENT STRATEGIES AND ENVIRONMENTAL/HEALTH IMPACTS; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Removal of Pharmaceuticals in Conventional Wastewater Treatment Plants; Abstract; 1. Introduction; 2. Pharmaceuticals Fate in Conventional WWTPs; 3. Occurrence and Removal of Pharmaceuticals in Conventional WWTPs; a) Analgesics and Anti-Inflammatory Drugs; b) Antibiotics; c) Blood Lipid Regulators; d) Beta-Blockers | |
505 | 8 | |a E) Psycho/Neuroactive Drugs3.1. Occurrence in WWTP Influents and Effluents and Removal Efficiency; 3.2. Occurrence of Pharmaceuticals in Sewage Sludge; 4. Main Removal Processes for Pharmaceuticals in WWTPs; a) Sorption on Sludge; b) Biodegradation; c) Abiotic Transformation; c1) Photodegradation; 5. Factors Affecting the Removal of Pharmaceuticals in WWTPs; a) Physico-Chemical Properties of Pharmaceuticals; b) Environmental Conditions; c) Wastewater Characteristics; d) Operation Parameters; 6. Alternative/Complementary Removal Technologies in WWTPs; 6.1. Advanced Treatment Technologies | |
505 | 8 | |a A) Activated Carbon Adsorptionb) Membrane Processes; b1) Membrane Bioreactor (MBR) for Wastewater Treatment; c) Advanced Oxidation Processes (AOP); 6.2. Constructed Wetlands; Conclusion; References; Chapter 2: Molecular Characterization of Microbial Communities in Constructed Wetlands: The Effect of Plant Species, Organic Matter and Hydraulic Design; Experimental Pilot Plant; Collection of Samples; DNA Extraction; PCR-DGGE Fingerprinting; rRNA Sequencing; Accession Numbers; Quantitative Analyses; Results; Bacterial Community Composition; Analysis of Predominant Bacterial Species by PCR-DGGE | |
505 | 8 | |a Bacterial Assemblage Diversity as Revealed by DGGEDifferences between Plant Species Microbial Communities; The Effect of Plants and Hydraulic Design on Microbial Communities; Acknowledgments; References; Chapter 3: Assessment of the Presence of Triclosan in Wastewater Treatment Plants in the Czech Republic and Alternative Fungal Treatment; 1Institute of Microbiology, Academy of Sciences of the Czech Republic,; Prague, Czech Republic; 2DEKONTA a.s, , Prague, Czech Republic; 3Institute for Environmental Studies, Faculty of Science,; Charles University in Prague, Prague, Czech Republic; Abstract | |
505 | 8 | |a IntroductionMaterial and Methods; Results and Discussion; Concentrations of TCS and in WWTPs (Pre-Screening); TCS Concentration Course in 24 Hours Experiment; TCS Removal in Bioreactor; Conclusion; Acknowledgment; References; Chapter 4: Removal of Pharmaceuticals and Personal Care Products from Wastewater; Abstract; 1. Introduction; 2. Occurrence of PPCPs in Aquatic Environments; 2.1. PPCPs in Water Supply Sources; 2.2. PPCPs in Drinking Water; 3. Removal of PPCPs during Treatment Processes; 3.1. Advances Oxidation Processes (AOPs); 3.1.1. Photocatalysis | |
505 | 8 | |a Over the past few years, the occurrence of pharmaceutical residues in the environment has attracted great interest regarding the possible harmful effects of many of these pollutants to living organisms. One of the main sources of pharmaceuticals in the environment is the discharge of effluents from wastewater treatment plants (WWTPs), where their removal is often incomplete. Natural wastewater treatment systems such as constructed wetlands constitute a relevant option to conventional methods due to their efficiency, low establishment costs and reduced operation and management requirements. Thi | |
650 | 7 | |a TECHNOLOGY & ENGINEERING / Environmental / General |2 bisacsh | |
650 | 7 | |a Sewage / Purification |2 fast | |
650 | 7 | |a Sewage / Purification / Environmental aspects |2 fast | |
650 | 7 | |a Sewage / Purification / Health aspects |2 fast | |
650 | 4 | |a Sewage disposal | |
650 | 4 | |a Umwelt | |
650 | 4 | |a Sewage |x Purification |a Sewage |x Purification |x Environmental aspects |a Sewage |x Purification |x Health aspects | |
700 | 1 | |a Barrett, Lydia M. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Wastewater treatment (Hauppauge, N |t Y.). Wastewater treatment |
912 | |a ZDB-4-EBA | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-029195782 | ||
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1020634 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1020634 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext |
Datensatz im Suchindex
_version_ | 1804176617976627200 |
---|---|
any_adam_object | |
author2 | Barrett, Lydia M. |
author2_role | edt |
author2_variant | l m b lm lmb |
author_facet | Barrett, Lydia M. |
building | Verbundindex |
bvnumber | BV043784722 |
collection | ZDB-4-EBA |
contents | WASTEWATER TREATMENT: PROCESSES, MANAGEMENT STRATEGIES AND ENVIRONMENTAL/HEALTH IMPACTS; WASTEWATER TREATMENT: PROCESSES, MANAGEMENT STRATEGIES AND ENVIRONMENTAL/HEALTH IMPACTS; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Removal of Pharmaceuticals in Conventional Wastewater Treatment Plants; Abstract; 1. Introduction; 2. Pharmaceuticals Fate in Conventional WWTPs; 3. Occurrence and Removal of Pharmaceuticals in Conventional WWTPs; a) Analgesics and Anti-Inflammatory Drugs; b) Antibiotics; c) Blood Lipid Regulators; d) Beta-Blockers E) Psycho/Neuroactive Drugs3.1. Occurrence in WWTP Influents and Effluents and Removal Efficiency; 3.2. Occurrence of Pharmaceuticals in Sewage Sludge; 4. Main Removal Processes for Pharmaceuticals in WWTPs; a) Sorption on Sludge; b) Biodegradation; c) Abiotic Transformation; c1) Photodegradation; 5. Factors Affecting the Removal of Pharmaceuticals in WWTPs; a) Physico-Chemical Properties of Pharmaceuticals; b) Environmental Conditions; c) Wastewater Characteristics; d) Operation Parameters; 6. Alternative/Complementary Removal Technologies in WWTPs; 6.1. Advanced Treatment Technologies A) Activated Carbon Adsorptionb) Membrane Processes; b1) Membrane Bioreactor (MBR) for Wastewater Treatment; c) Advanced Oxidation Processes (AOP); 6.2. Constructed Wetlands; Conclusion; References; Chapter 2: Molecular Characterization of Microbial Communities in Constructed Wetlands: The Effect of Plant Species, Organic Matter and Hydraulic Design; Experimental Pilot Plant; Collection of Samples; DNA Extraction; PCR-DGGE Fingerprinting; rRNA Sequencing; Accession Numbers; Quantitative Analyses; Results; Bacterial Community Composition; Analysis of Predominant Bacterial Species by PCR-DGGE Bacterial Assemblage Diversity as Revealed by DGGEDifferences between Plant Species Microbial Communities; The Effect of Plants and Hydraulic Design on Microbial Communities; Acknowledgments; References; Chapter 3: Assessment of the Presence of Triclosan in Wastewater Treatment Plants in the Czech Republic and Alternative Fungal Treatment; 1Institute of Microbiology, Academy of Sciences of the Czech Republic,; Prague, Czech Republic; 2DEKONTA a.s, , Prague, Czech Republic; 3Institute for Environmental Studies, Faculty of Science,; Charles University in Prague, Prague, Czech Republic; Abstract IntroductionMaterial and Methods; Results and Discussion; Concentrations of TCS and in WWTPs (Pre-Screening); TCS Concentration Course in 24 Hours Experiment; TCS Removal in Bioreactor; Conclusion; Acknowledgment; References; Chapter 4: Removal of Pharmaceuticals and Personal Care Products from Wastewater; Abstract; 1. Introduction; 2. Occurrence of PPCPs in Aquatic Environments; 2.1. PPCPs in Water Supply Sources; 2.2. PPCPs in Drinking Water; 3. Removal of PPCPs during Treatment Processes; 3.1. Advances Oxidation Processes (AOPs); 3.1.1. Photocatalysis Over the past few years, the occurrence of pharmaceutical residues in the environment has attracted great interest regarding the possible harmful effects of many of these pollutants to living organisms. One of the main sources of pharmaceuticals in the environment is the discharge of effluents from wastewater treatment plants (WWTPs), where their removal is often incomplete. Natural wastewater treatment systems such as constructed wetlands constitute a relevant option to conventional methods due to their efficiency, low establishment costs and reduced operation and management requirements. Thi |
ctrlnum | (ZDB-4-EBA)ocn912876812 (OCoLC)912876812 (DE-599)BVBBV043784722 |
dewey-full | 628.3 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 628 - Sanitary engineering |
dewey-raw | 628.3 |
dewey-search | 628.3 |
dewey-sort | 3628.3 |
dewey-tens | 620 - Engineering and allied operations |
discipline | Bauingenieurwesen |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05664nmm a2200553zc 4500</leader><controlfield tag="001">BV043784722</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160920s2014 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781634824910</subfield><subfield code="9">978-1-63482-491-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1634824911</subfield><subfield code="9">1-63482-491-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781634824675</subfield><subfield code="9">978-1-63482-467-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1634824679</subfield><subfield code="9">1-63482-467-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-EBA)ocn912876812</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)912876812</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043784722</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">628.3</subfield><subfield code="2">23</subfield></datafield><datafield tag="130" ind1="0" ind2=" "><subfield code="a">Wastewater treatment (Hauppauge, N.Y.)</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Wastewater treatment</subfield><subfield code="b">processes, management strategies and environmental/health impacts</subfield><subfield code="c">editors, Lydia M. Barrett</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hauppauge, New York</subfield><subfield code="b">Nova Science Publishers, Inc.</subfield><subfield code="c">[2014]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Environmental science, engineering and technology series</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Print version record</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">WASTEWATER TREATMENT: PROCESSES, MANAGEMENT STRATEGIES AND ENVIRONMENTAL/HEALTH IMPACTS; WASTEWATER TREATMENT: PROCESSES, MANAGEMENT STRATEGIES AND ENVIRONMENTAL/HEALTH IMPACTS; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Removal of Pharmaceuticals in Conventional Wastewater Treatment Plants; Abstract; 1. Introduction; 2. Pharmaceuticals Fate in Conventional WWTPs; 3. Occurrence and Removal of Pharmaceuticals in Conventional WWTPs; a) Analgesics and Anti-Inflammatory Drugs; b) Antibiotics; c) Blood Lipid Regulators; d) Beta-Blockers</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">E) Psycho/Neuroactive Drugs3.1. Occurrence in WWTP Influents and Effluents and Removal Efficiency; 3.2. Occurrence of Pharmaceuticals in Sewage Sludge; 4. Main Removal Processes for Pharmaceuticals in WWTPs; a) Sorption on Sludge; b) Biodegradation; c) Abiotic Transformation; c1) Photodegradation; 5. Factors Affecting the Removal of Pharmaceuticals in WWTPs; a) Physico-Chemical Properties of Pharmaceuticals; b) Environmental Conditions; c) Wastewater Characteristics; d) Operation Parameters; 6. Alternative/Complementary Removal Technologies in WWTPs; 6.1. Advanced Treatment Technologies</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">A) Activated Carbon Adsorptionb) Membrane Processes; b1) Membrane Bioreactor (MBR) for Wastewater Treatment; c) Advanced Oxidation Processes (AOP); 6.2. Constructed Wetlands; Conclusion; References; Chapter 2: Molecular Characterization of Microbial Communities in Constructed Wetlands: The Effect of Plant Species, Organic Matter and Hydraulic Design; Experimental Pilot Plant; Collection of Samples; DNA Extraction; PCR-DGGE Fingerprinting; rRNA Sequencing; Accession Numbers; Quantitative Analyses; Results; Bacterial Community Composition; Analysis of Predominant Bacterial Species by PCR-DGGE</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Bacterial Assemblage Diversity as Revealed by DGGEDifferences between Plant Species Microbial Communities; The Effect of Plants and Hydraulic Design on Microbial Communities; Acknowledgments; References; Chapter 3: Assessment of the Presence of Triclosan in Wastewater Treatment Plants in the Czech Republic and Alternative Fungal Treatment; 1Institute of Microbiology, Academy of Sciences of the Czech Republic,; Prague, Czech Republic; 2DEKONTA a.s, , Prague, Czech Republic; 3Institute for Environmental Studies, Faculty of Science,; Charles University in Prague, Prague, Czech Republic; Abstract</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">IntroductionMaterial and Methods; Results and Discussion; Concentrations of TCS and in WWTPs (Pre-Screening); TCS Concentration Course in 24 Hours Experiment; TCS Removal in Bioreactor; Conclusion; Acknowledgment; References; Chapter 4: Removal of Pharmaceuticals and Personal Care Products from Wastewater; Abstract; 1. Introduction; 2. Occurrence of PPCPs in Aquatic Environments; 2.1. PPCPs in Water Supply Sources; 2.2. PPCPs in Drinking Water; 3. Removal of PPCPs during Treatment Processes; 3.1. Advances Oxidation Processes (AOPs); 3.1.1. Photocatalysis</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Over the past few years, the occurrence of pharmaceutical residues in the environment has attracted great interest regarding the possible harmful effects of many of these pollutants to living organisms. One of the main sources of pharmaceuticals in the environment is the discharge of effluents from wastewater treatment plants (WWTPs), where their removal is often incomplete. Natural wastewater treatment systems such as constructed wetlands constitute a relevant option to conventional methods due to their efficiency, low establishment costs and reduced operation and management requirements. Thi</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TECHNOLOGY & ENGINEERING / Environmental / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sewage / Purification</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sewage / Purification / Environmental aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sewage / Purification / Health aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sewage disposal</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Umwelt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sewage</subfield><subfield code="x">Purification</subfield><subfield code="a">Sewage</subfield><subfield code="x">Purification</subfield><subfield code="x">Environmental aspects</subfield><subfield code="a">Sewage</subfield><subfield code="x">Purification</subfield><subfield code="x">Health aspects</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barrett, Lydia M.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Wastewater treatment (Hauppauge, N</subfield><subfield code="t">Y.). Wastewater treatment</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029195782</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1020634</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1020634</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV043784722 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:35:02Z |
institution | BVB |
isbn | 9781634824910 1634824911 9781634824675 1634824679 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029195782 |
oclc_num | 912876812 |
open_access_boolean | |
owner | DE-1046 DE-1047 |
owner_facet | DE-1046 DE-1047 |
physical | 1 online resource |
psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
publishDate | 2014 |
publishDateSearch | 2014 |
publishDateSort | 2014 |
publisher | Nova Science Publishers, Inc. |
record_format | marc |
series2 | Environmental science, engineering and technology series |
spelling | Wastewater treatment (Hauppauge, N.Y.) Wastewater treatment processes, management strategies and environmental/health impacts editors, Lydia M. Barrett Hauppauge, New York Nova Science Publishers, Inc. [2014] 1 online resource txt rdacontent c rdamedia cr rdacarrier Environmental science, engineering and technology series Print version record WASTEWATER TREATMENT: PROCESSES, MANAGEMENT STRATEGIES AND ENVIRONMENTAL/HEALTH IMPACTS; WASTEWATER TREATMENT: PROCESSES, MANAGEMENT STRATEGIES AND ENVIRONMENTAL/HEALTH IMPACTS; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Removal of Pharmaceuticals in Conventional Wastewater Treatment Plants; Abstract; 1. Introduction; 2. Pharmaceuticals Fate in Conventional WWTPs; 3. Occurrence and Removal of Pharmaceuticals in Conventional WWTPs; a) Analgesics and Anti-Inflammatory Drugs; b) Antibiotics; c) Blood Lipid Regulators; d) Beta-Blockers E) Psycho/Neuroactive Drugs3.1. Occurrence in WWTP Influents and Effluents and Removal Efficiency; 3.2. Occurrence of Pharmaceuticals in Sewage Sludge; 4. Main Removal Processes for Pharmaceuticals in WWTPs; a) Sorption on Sludge; b) Biodegradation; c) Abiotic Transformation; c1) Photodegradation; 5. Factors Affecting the Removal of Pharmaceuticals in WWTPs; a) Physico-Chemical Properties of Pharmaceuticals; b) Environmental Conditions; c) Wastewater Characteristics; d) Operation Parameters; 6. Alternative/Complementary Removal Technologies in WWTPs; 6.1. Advanced Treatment Technologies A) Activated Carbon Adsorptionb) Membrane Processes; b1) Membrane Bioreactor (MBR) for Wastewater Treatment; c) Advanced Oxidation Processes (AOP); 6.2. Constructed Wetlands; Conclusion; References; Chapter 2: Molecular Characterization of Microbial Communities in Constructed Wetlands: The Effect of Plant Species, Organic Matter and Hydraulic Design; Experimental Pilot Plant; Collection of Samples; DNA Extraction; PCR-DGGE Fingerprinting; rRNA Sequencing; Accession Numbers; Quantitative Analyses; Results; Bacterial Community Composition; Analysis of Predominant Bacterial Species by PCR-DGGE Bacterial Assemblage Diversity as Revealed by DGGEDifferences between Plant Species Microbial Communities; The Effect of Plants and Hydraulic Design on Microbial Communities; Acknowledgments; References; Chapter 3: Assessment of the Presence of Triclosan in Wastewater Treatment Plants in the Czech Republic and Alternative Fungal Treatment; 1Institute of Microbiology, Academy of Sciences of the Czech Republic,; Prague, Czech Republic; 2DEKONTA a.s, , Prague, Czech Republic; 3Institute for Environmental Studies, Faculty of Science,; Charles University in Prague, Prague, Czech Republic; Abstract IntroductionMaterial and Methods; Results and Discussion; Concentrations of TCS and in WWTPs (Pre-Screening); TCS Concentration Course in 24 Hours Experiment; TCS Removal in Bioreactor; Conclusion; Acknowledgment; References; Chapter 4: Removal of Pharmaceuticals and Personal Care Products from Wastewater; Abstract; 1. Introduction; 2. Occurrence of PPCPs in Aquatic Environments; 2.1. PPCPs in Water Supply Sources; 2.2. PPCPs in Drinking Water; 3. Removal of PPCPs during Treatment Processes; 3.1. Advances Oxidation Processes (AOPs); 3.1.1. Photocatalysis Over the past few years, the occurrence of pharmaceutical residues in the environment has attracted great interest regarding the possible harmful effects of many of these pollutants to living organisms. One of the main sources of pharmaceuticals in the environment is the discharge of effluents from wastewater treatment plants (WWTPs), where their removal is often incomplete. Natural wastewater treatment systems such as constructed wetlands constitute a relevant option to conventional methods due to their efficiency, low establishment costs and reduced operation and management requirements. Thi TECHNOLOGY & ENGINEERING / Environmental / General bisacsh Sewage / Purification fast Sewage / Purification / Environmental aspects fast Sewage / Purification / Health aspects fast Sewage disposal Umwelt Sewage Purification Sewage Purification Environmental aspects Sewage Purification Health aspects Barrett, Lydia M. edt Erscheint auch als Druck-Ausgabe Wastewater treatment (Hauppauge, N Y.). Wastewater treatment |
spellingShingle | Wastewater treatment processes, management strategies and environmental/health impacts WASTEWATER TREATMENT: PROCESSES, MANAGEMENT STRATEGIES AND ENVIRONMENTAL/HEALTH IMPACTS; WASTEWATER TREATMENT: PROCESSES, MANAGEMENT STRATEGIES AND ENVIRONMENTAL/HEALTH IMPACTS; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Removal of Pharmaceuticals in Conventional Wastewater Treatment Plants; Abstract; 1. Introduction; 2. Pharmaceuticals Fate in Conventional WWTPs; 3. Occurrence and Removal of Pharmaceuticals in Conventional WWTPs; a) Analgesics and Anti-Inflammatory Drugs; b) Antibiotics; c) Blood Lipid Regulators; d) Beta-Blockers E) Psycho/Neuroactive Drugs3.1. Occurrence in WWTP Influents and Effluents and Removal Efficiency; 3.2. Occurrence of Pharmaceuticals in Sewage Sludge; 4. Main Removal Processes for Pharmaceuticals in WWTPs; a) Sorption on Sludge; b) Biodegradation; c) Abiotic Transformation; c1) Photodegradation; 5. Factors Affecting the Removal of Pharmaceuticals in WWTPs; a) Physico-Chemical Properties of Pharmaceuticals; b) Environmental Conditions; c) Wastewater Characteristics; d) Operation Parameters; 6. Alternative/Complementary Removal Technologies in WWTPs; 6.1. Advanced Treatment Technologies A) Activated Carbon Adsorptionb) Membrane Processes; b1) Membrane Bioreactor (MBR) for Wastewater Treatment; c) Advanced Oxidation Processes (AOP); 6.2. Constructed Wetlands; Conclusion; References; Chapter 2: Molecular Characterization of Microbial Communities in Constructed Wetlands: The Effect of Plant Species, Organic Matter and Hydraulic Design; Experimental Pilot Plant; Collection of Samples; DNA Extraction; PCR-DGGE Fingerprinting; rRNA Sequencing; Accession Numbers; Quantitative Analyses; Results; Bacterial Community Composition; Analysis of Predominant Bacterial Species by PCR-DGGE Bacterial Assemblage Diversity as Revealed by DGGEDifferences between Plant Species Microbial Communities; The Effect of Plants and Hydraulic Design on Microbial Communities; Acknowledgments; References; Chapter 3: Assessment of the Presence of Triclosan in Wastewater Treatment Plants in the Czech Republic and Alternative Fungal Treatment; 1Institute of Microbiology, Academy of Sciences of the Czech Republic,; Prague, Czech Republic; 2DEKONTA a.s, , Prague, Czech Republic; 3Institute for Environmental Studies, Faculty of Science,; Charles University in Prague, Prague, Czech Republic; Abstract IntroductionMaterial and Methods; Results and Discussion; Concentrations of TCS and in WWTPs (Pre-Screening); TCS Concentration Course in 24 Hours Experiment; TCS Removal in Bioreactor; Conclusion; Acknowledgment; References; Chapter 4: Removal of Pharmaceuticals and Personal Care Products from Wastewater; Abstract; 1. Introduction; 2. Occurrence of PPCPs in Aquatic Environments; 2.1. PPCPs in Water Supply Sources; 2.2. PPCPs in Drinking Water; 3. Removal of PPCPs during Treatment Processes; 3.1. Advances Oxidation Processes (AOPs); 3.1.1. Photocatalysis Over the past few years, the occurrence of pharmaceutical residues in the environment has attracted great interest regarding the possible harmful effects of many of these pollutants to living organisms. One of the main sources of pharmaceuticals in the environment is the discharge of effluents from wastewater treatment plants (WWTPs), where their removal is often incomplete. Natural wastewater treatment systems such as constructed wetlands constitute a relevant option to conventional methods due to their efficiency, low establishment costs and reduced operation and management requirements. Thi TECHNOLOGY & ENGINEERING / Environmental / General bisacsh Sewage / Purification fast Sewage / Purification / Environmental aspects fast Sewage / Purification / Health aspects fast Sewage disposal Umwelt Sewage Purification Sewage Purification Environmental aspects Sewage Purification Health aspects |
title | Wastewater treatment processes, management strategies and environmental/health impacts |
title_alt | Wastewater treatment (Hauppauge, N.Y.) |
title_auth | Wastewater treatment processes, management strategies and environmental/health impacts |
title_exact_search | Wastewater treatment processes, management strategies and environmental/health impacts |
title_full | Wastewater treatment processes, management strategies and environmental/health impacts editors, Lydia M. Barrett |
title_fullStr | Wastewater treatment processes, management strategies and environmental/health impacts editors, Lydia M. Barrett |
title_full_unstemmed | Wastewater treatment processes, management strategies and environmental/health impacts editors, Lydia M. Barrett |
title_short | Wastewater treatment |
title_sort | wastewater treatment processes management strategies and environmental health impacts |
title_sub | processes, management strategies and environmental/health impacts |
topic | TECHNOLOGY & ENGINEERING / Environmental / General bisacsh Sewage / Purification fast Sewage / Purification / Environmental aspects fast Sewage / Purification / Health aspects fast Sewage disposal Umwelt Sewage Purification Sewage Purification Environmental aspects Sewage Purification Health aspects |
topic_facet | TECHNOLOGY & ENGINEERING / Environmental / General Sewage / Purification Sewage / Purification / Environmental aspects Sewage / Purification / Health aspects Sewage disposal Umwelt Sewage Purification Sewage Purification Environmental aspects Sewage Purification Health aspects |
work_keys_str_mv | UT wastewatertreatmenthauppaugeny AT barrettlydiam wastewatertreatmentprocessesmanagementstrategiesandenvironmentalhealthimpacts |